Human IgG antibody Laboratories manufactures the lclaboratories ibrutinib i-3311 reagents distributed by Genprice. The Lclaboratories Ibrutinib I-3311 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact LC laboratories. Other Lclaboratories products are available in stock. Specificity: Lclaboratories Category: Ibrutinib Group: I-3311
PCI-32765 (Ibrutinib) |
ApexBio |
10 mg |
EUR 170.4 |
Description: PCI-32765, also named as Ibrutinib, is a Bruton tyrosine kinase inhibitor which is used to study the biological effects of Bruton tyrosine kinase inhibition on mature B-cell function and the progression of B cell-associated diseases in vivo. |
PCI-32765 (Ibrutinib) |
ApexBio |
200 mg |
EUR 686.4 |
Description: PCI-32765, also named as Ibrutinib, is a Bruton tyrosine kinase inhibitor which is used to study the biological effects of Bruton tyrosine kinase inhibition on mature B-cell function and the progression of B cell-associated diseases in vivo. |
I-3311 information
FK 3311 |
A3416-10 |
ApexBio |
10 mg |
EUR 351.6 |
Description: FK 3311, a cell-permeable and orally available sulfonanilide, is a highly selective inhibitor of cyclooxygenase (COX)-2 with IC 50 value of 1.6 ?M.Cyclooxygenase-2 (COX-2) is a membrane bound enzyme that transfers the electrons from cytochrome c to the catalytic subunit 1. |
FK 3311 |
A3416-5 |
ApexBio |
5 mg |
EUR 265.2 |
Description: FK 3311, a cell-permeable and orally available sulfonanilide, is a highly selective inhibitor of cyclooxygenase (COX)-2 with IC 50 value of 1.6 ?M.Cyclooxygenase-2 (COX-2) is a membrane bound enzyme that transfers the electrons from cytochrome c to the catalytic subunit 1. |
I-BRD9 |
B6169-1 |
ApexBio |
1 mg |
EUR 158.4 |
Description: pIC50: 7.3I-BRD9 is a BRD9 inhibitor. BRD9 is identified as a bromodomain containing protein forming a small sub-branch of the bromodomain family tree. Human BRD9 has a single bromodomain and contains five isoforms which are produced by alternative splicing. |
I-BRD9 |
B6169-10 |
ApexBio |
10 mg |
EUR 374.4 |
Description: pIC50: 7.3I-BRD9 is a BRD9 inhibitor. BRD9 is identified as a bromodomain containing protein forming a small sub-branch of the bromodomain family tree. Human BRD9 has a single bromodomain and contains five isoforms which are produced by alternative splicing. |
I-BRD9 |
B6169-5 |
ApexBio |
5 mg |
EUR 255.6 |
Description: pIC50: 7.3I-BRD9 is a BRD9 inhibitor. BRD9 is identified as a bromodomain containing protein forming a small sub-branch of the bromodomain family tree. Human BRD9 has a single bromodomain and contains five isoforms which are produced by alternative splicing. |
I-BRD9 |
B6169-50 |
ApexBio |
50 mg |
EUR 1390.8 |
Description: pIC50: 7.3I-BRD9 is a BRD9 inhibitor. BRD9 is identified as a bromodomain containing protein forming a small sub-branch of the bromodomain family tree. Human BRD9 has a single bromodomain and contains five isoforms which are produced by alternative splicing. |
i-BRITE Plus |
SF40000-10 |
Neuromics |
10 ml |
EUR 292.8 |
LCLAT1 siRNA |
20-abx922342 |
Abbexa |
|
|
|
LCLAT1 siRNA |
20-abx922343 |
Abbexa |
|
|
|
LCLAT1 ORF Vector (Human) (pORF) |
ORF022644 |
ABM |
1.0 ug DNA |
EUR 486 |
Lclat1 ORF Vector (Mouse) (pORF) |
ORF049013 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Lclat1 ORF Vector (Mouse) (pORF) |
ORF049014 |
ABM |
1.0 ug DNA |
EUR 607.2 |